Osteonecrosis of the Jaw in a Patient on Denosumab

被引：186
作者：
Aghaloo, Tara L. [1 ]
Felsenfeld, Alan L. [1 ]
Tetradis, Sotirios [1 ]
机构：
[1] Univ Calif Los Angeles, Sch Dent, Sect Oral & Maxillofacial Surg, Los Angeles, CA 90095 USA
来源：
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY | 2010年 / 68卷 / 05期
关键词：
BISPHOSPHONATE-RELATED OSTEONECROSIS; GIANT-CELL TUMOR; FACTOR-KAPPA-B; RISK-FACTORS; POSTMENOPAUSAL WOMEN; BONE METASTASES; BREAST-CANCER; RECEPTOR ACTIVATOR; MULTIPLE-MYELOMA; AVASCULAR NECROSIS;
D O I：
10.1016/j.joms.2009.10.010
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
[No abstract available]
引用
收藏
页码：959 / 963
页数：5
相关论文
共 65 条
  • [1] The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
    Allen, Matthew R.
    Burr, David B.
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) : 61 - 70
  • [2] Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases
    Bagan, JV
    Murillo, J
    Jimenez, Y
    Poveda, R
    Milian, MA
    Sanchis, JM
    Silvestre, FJ
    Scully, C
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) : 120 - 123
  • [3] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
    Bamias, A
    Kastritis, E
    Bamia, C
    Moulopoulos, LA
    Melakopoulos, L
    Bozas, G
    Koutsoukou, V
    Gika, D
    Anagnostopoulos, A
    Papadimitriou, C
    Terpos, E
    Dimopoulos, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8580 - 8587
  • [4] RANKL, RANK, osteoprotegerin:: key partners of osteoimmunology and vascular diseases
    Baud'huin, M.
    Lamoureuxa, F.
    Duplomba, L.
    Redini, F.
    Heymann, D.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (18) : 2334 - 2350
  • [5] A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
    Bekker, PJ
    Holloway, DL
    Rasmussen, AS
    Murphy, R
    Martin, SW
    Leese, PT
    Holmes, GB
    Dunstan, CR
    DePaoli, AM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) : 1059 - 1066
  • [6] A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer
    Body, JJ
    Facon, T
    Coleman, RE
    Lipton, A
    Geurs, F
    Fan, M
    Holloway, D
    Peterson, MC
    Bekker, P
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1221 - 1228
  • [7] Ten years' experience with alendronate for osteoporosis in postmenopausal women
    Bone, HG
    Hosking, D
    Devogelaer, J
    Tucci, JR
    Emkey, RD
    Tonino, RP
    Rodriguez-Portales, JA
    Downs, RW
    Gupta, J
    Santora, AC
    Liberman, UA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) : 1189 - 1199
  • [8] Osteoclast differentiation and activation
    Boyle, WJ
    Simonet, WS
    Lacey, DL
    [J]. NATURE, 2003, 423 (6937) : 337 - 342
  • [9] Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/jbmr.080901, 10.1359/JBMR.0809010]
  • [10] Bisphosphonates and jaw osteonecrosis: The UAMS experience
    Clarke, Brett M.
    Boyette, Jennings
    Vural, Emre
    Suen, James Y.
    Anaissie, Elias J.
    Stack, Brendan C., Jr.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (03) : 396 - 400
1234567